Related Experiment Videos
Failure of allopurinol to improve left ventricular stroke work after cardiopulmonary bypass surgery
A Coetzee1, G Roussouw, L Macgregor
1Department of Anesthesiology, University of Stellenbosch Medical School, Tygerberg, South Africa.
Insights
Preoperative allopurinol did not improve left ventricular function in patients undergoing coronary artery bypass surgery. This study found no significant difference in left ventricular stroke work index between groups.
Area of Science:
- Cardiology
- Cardiac Surgery
- Pharmacology
Background:
- Coronary artery bypass surgery (CABS) is a major cardiac procedure.
- Left ventricular (LV) function is crucial for patient outcomes post-CABS.
- Allopurinol is a xanthine oxidase inhibitor with potential cardioprotective effects.
Purpose of the Study:
- To investigate the impact of preoperative allopurinol administration on global left ventricular function following coronary artery bypass surgery.
- To assess the efficacy of allopurinol in preserving or enhancing left ventricular stroke work index (LVSWI) in the perioperative period of CABS.
Main Methods:
- A randomized, prospective, partially blinded study involving 52 patients undergoing elective coronary artery bypass surgery.
- Patients received either 400 mg of allopurinol orally 18 hours and 3 hours before surgery, or a placebo.
- Global left ventricular function was evaluated using the left ventricular stroke work index (LVSWI) at multiple time points: pre-anesthesia, post-anesthesia induction, and at 15 minutes, 6, 12, and 24 hours after cardiopulmonary bypass.
Main Results:
- No statistically significant difference in LVSWI was observed between the allopurinol group and the placebo group.
- LVSWI measurements before and after surgery showed no improvement in the allopurinol-treated patients compared to controls.
- The administration of preoperative allopurinol did not alter global left ventricular function in the context of coronary artery bypass surgery.
Conclusions:
- Preoperative allopurinol administration is not associated with improved left ventricular stroke work in patients undergoing coronary artery bypass surgery.
- The findings suggest that allopurinol does not offer significant cardioprotection in this specific surgical setting.
- Further research may be needed to explore alternative dosing regimens or patient populations for potential benefits of allopurinol in cardiac surgery.
Objective:
This study examined the effects of allopurinol on global left ventricular function after coronary artery bypass surgery.
Design:
A randomized prospective partially blinded study in 52 patients undergoing elective coronary artery bypass surgery.
Setting:
Conducted in a university-affiliated tertiary care facility.
Interventions:
Participants received 400 mg of allopurinol 18 hours and 400 mg of allopurinol orally 3 hours before surgery or no allopurinol. Patients then received a standard anesthetic technique consisting of target-controlled opiate infusion and inhalation anesthesia. Coronary artery bypass was performed using moderate hypothermia and oxygenated crystalloid cardioplegia.
Measurements And Main Results:
Global left ventricular function was assessed by means of left ventricular stroke work index (LVSWI) calculated before and after induction of anesthesia and after cardiopulmonary bypass at 15 minutes, 6, 12 and 24 hours. There was no difference in the LVSWI before or after surgery when the two groups were compared.
Conclusions:
In this population sample, the use of preoperative allopurinol did not result in improved left ventricular stroke work after coronary artery bypass surgery.